share_log
Reuters ·  Apr 29 08:32
X4 Pharmaceuticals Inc - Set Wholesale Acquisition Cost for Xolremdi on an Annual Basis to $496,400 for Patients Greater Than 50 Kilograms
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment